Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Brainstorm Cell Therapeutics Inc. (BCLI) had Weighted-Average Shares Outstanding (Diluted) of 5.02M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.62M |
|
-- |
|
-- |
|
$11.69M |
|
$-11.69M |
|
$0.07M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.69M |
|
$-11.45M |
|
5.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.02M |
$-2.31 |
|
$-2.31 |
|
| Balance Sheet Financials | |
$0.39M |
|
$0.43M |
|
$1.45M |
|
$1.83M |
|
$8.98M |
|
-- |
|
$0.62M |
|
$9.60M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
6.14M |
|
| Cash Flow Statement Financials | |
$-9.09M |
|
$0.01M |
|
$7.97M |
|
$1.49M |
|
$0.37M |
|
$-1.11M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
149.70% |
|
149.70% |
|
-634.44% |
|
149.70% |
|
$-1.26 |
|
$-1.81 |
|
$-1.81 |
|